The Growing Primary Biliary Cholangitis Treatment Market: A Journey Towards $2.72 Billion by 2033 The Primary Biliary Cholangitis treatment market is projected to soar to $2.72 billion by 2033, driven by advancements in therapies and rising patient numbers.

The Growing Primary Biliary Cholangitis Treatment Market: A Journey Towards $2.72 Billion by 2033 #USA #Austin #PBC_Treatment #FXR_Agonists #Immunomodulators

Dr Nathalie Boulanger reviews #tick & host #microbiotas: #immunomodulators in #tickborne diseases. #Microbiota #Metagenomics #Skin #Immunity #Immunomodulation @chrustrasbourg.bsky.social‬

authors.elsevier.com/a/1lZFX5Eb1x...

A new article in @critcareexplore.bsky.social by our Senior Scholar @ameshaa.bsky.social and Director @t-inglesby.bsky.social proposes policy recommendations for an innovative strategy to combat future #pandemics: stockpiling #immunomodulators.